Magellan Petroleum Corporation  

(Public, NASDAQ:MPET)   Watch this stock  
Find more results for MPET
5.40
+0.03 (0.56%)
Real-time:   10:55AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.30 - 5.48
52 week 0.20 - 7.17
Open 5.46
Vol / Avg. 35,522.00/306,364.00
Mkt cap 33.30M
P/E     -
Div/yield     -
EPS -0.17
Shares 5.88M
Beta 0.56
Inst. own 10%

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets 24.92% -8.51%
Return on average equity - -204.81%
Employees 20 -
CDP Score - -

Address

1775 Sherman St Ste 1950
DENVER, CO 80203-4350
United States - Map
+1-720-4842400 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Magellan Petroleum Corporation is an oil and gas exploration and production company. The Company focuses on the development of liquefied natural gas (LNG) projects along the United States Gulf Coast. It conducts its operations through two subsidiaries corresponding to the geographical areas in which the Company operates: Magellan Petroleum (UK) Limited (MPUK) and Magellan Petroleum Australia Pty Ltd (MPA). As of June 30, 2016, it had two geographic segments: MPUK and MPA, corresponding to its operations in the United Kingdom and Australia, respectively. It owns interests in the Horse Hill-1 well and related licenses, which consist of PEDLs 137 and 246 in the Weald Basin, onshore the United Kingdom. MPUK's oil and gas assets consist of various exploration licenses in or adjacent to the Weald Basin located onshore and offshore southern England. MPA's oil and gas assets consist of NT/P82, which is an exploration block in the Bonaparte Basin, offshore Northern Territory, Australia.

Officers and directors

Antoine Jean Lafargue President, Chief Executive Officer, Chief Financial Officer, Senior Vice President, Treasurer, Corporate Secretary
Age: 41
Bio & Compensation  - Reuters
Milam Randolph Pharo Director
Age: 62
Bio & Compensation  - Reuters